Inventor · disambiguated record
Marco Colonna
Also filed as: COLONNA MARCO
7 granted patents·12 pending applications·85 citations·filing 2002–2022
80Inventor score
Top patents by PatentIndex Score
19 records- 0195US8981061B2Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereofNOVO NORDISK AS·Filed 2012·Granted Mar 17, 2015·41 cites·2 claims
- 0291US8231878B2Receptor trem (triggering receptor expressed on myeloid cells) and uses thereofCOLONNA MARCO·Filed 2009·Granted Jul 31, 2012·43 cites·6 claims
- 0362US11066456B2Compositions comprising TREM2 and methods of use thereofUNIV WASHINGTON·Filed 2017·Granted Jul 20, 2021·1 cites·7 claims
- 0461US12226382B2Methods for treating microglial dysfunctionWASHINGTON UNIVERSITY ST LOUIS·Filed 2021·Granted Feb 18, 2025·0 cites·9 claims
- 0556US2017320946A1Receptor trem (triggering receptor expressed on myeloid cells) and uses thereofNOVO NORDISK AS·Filed 2017·Application pending·0 cites
- 0655US11952417B2Anti-IL12RB1 antibodiesWASHINGTON UNIVERSITY ST LOUIS·Filed 2021·Granted Apr 9, 2024·0 cites·18 claims
- 0755US2009081199A1Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereofBIOXELL SPA·Filed 2008·Application pending·0 cites
- 0854US2013028901A1Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereofNOVO NORDISK AS·Filed 2012·Application pending·0 cites
- 0953US11596655B2Activation of natural cytotoxicity receptor 2 (NCR2)COLONNA MARCO·Filed 2018·Granted Mar 7, 2023·0 cites·6 claims
- 1052US2023183340A1Compositions and Methods for Reducing Resistance to or Enhancing ImmunotherapyWASHINGTON UNIVERSITY ST LOUIS·Filed 2021·Application pending·0 cites
- 1152US2005260670A1Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereofCOLONNA MARCO·Filed 2005·Application pending·0 cites
- 1251US2016251434A1Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereofNOVO NORDISK AS·Filed 2015·Application pending·0 cites
- 1350US2023285338A9Methods for treating microglial dysfunctionWASHINGTON UNIVERSITY ST LOUIS·Filed 2022·Application pending·0 cites
- 1449US2019008812A1Methods for treating microglial dysfunctionUNIV WASHINGTON·Filed 2018·Application pending·0 cites
- 1548US2003165875A1Novel receptor TREM (triggering receptor expressed on myeloid cells) and uses thereofFiled 2002·Application pending·0 cites
- 1646US2010305306A1Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereofBIOXELL SPA·Filed 2010·Application pending·0 cites
- 1745US2006263770A1Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereofCOLONNA MARCO·Filed 2003·Application pending·0 cites
- 1844US2010306863A1Screening, therapy and diagnosisBIOXELL SPA·Filed 2008·Application pending·0 cites
- 1942US8389694B2Biologically active antibodies recognizing a cell surface molecule selectively expressed on living mouse natural type one (I) interferon producing cellsBLASIUS AMANDA L·Filed 2004·Granted Mar 5, 2013·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Marco Colonna files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →